{
    "elements": [
        {
            "data": {
                "is_heading": 1,
                "text": "Mid & South Essex NHS Foundation Trust"
            },
            "type": "ListItem",
            "sequence_num": 1
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 3,
                "num_cols": 7,
                "table_items": [
                    {
                        "text": "Ref:"
                    },
                    {
                        "text": "MSEGL-20003"
                    },
                    {
                        "text": "Version:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "04/12/2020"
                    },
                    {
                        "text": "Review date:"
                    },
                    {
                        "text": "03/12/2023"
                    },
                    {
                        "text": "Approved by:"
                    },
                    {
                        "text": "BTUH Medicines Management Committee (29/10/2020), MEH Medicines Optimisation and Safety group (16/11/2020), SUH Medicine Optimisation Committee (19/10/2020)"
                    },
                    {
                        "text": "Ratified by:"
                    },
                    {
                        "text": "Joint Document Management Group (03/11/2020)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Guideline on use of Corticosteroids for the treatment of COVID-19"
            },
            "type": "ListItem",
            "sequence_num": 3
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 4
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Corticosteroids, and in particular dexamethasone and hydrocortisone1-3, have been demonstrated to have a place in the management of patients with COVID-19."
            },
            "type": "ListItem",
            "sequence_num": 5
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Indication"
            },
            "type": "ListItem",
            "sequence_num": 6
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Corticosteroids  should  not  normally  be  prescribed in  patients  with  COVID-19  that is not severe or critical, because there is the possibility of harm to such patients1,2."
            },
            "type": "ListItem",
            "sequence_num": 7
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For the treatment of severe and critical COVID-19 infection patients with any of the following:"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "text": "acute respiratory distress syndrome (ARDS)"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "text": "sepsis or septic shock"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "text": "other conditions that would normally need life-sustaining therapies such as ventilation or vasopressor therapy"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "text": "signs of severe respiratory distress (i.e. accessory muscle use, inability to complete full sentences; and in children, very severe chest wall in-drawing, grunting, central cyanosis, or presence of any other general danger signs)."
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "text": "oxygen saturation <90% (or deteriorating) on air"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 1,
                "text": "increased respiratory rate"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Treatment"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For treating COVID-19:"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "text": "- Dexamethasone can be given orally or intravenously"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "text": "- Hydrocortisone can only be given intravenously."
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The recommended dosage and duration of treatment for adults is:"
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Oral: Prescribe tablets for patients able to swallow and in whom there are no significant concerns about enteral absorption"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Dexamethasone 6mg (3 x 2mg tablets) ONCE daily 7 to 10 days1,2,3,4 Dexamethasone solution also available"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Intravenous: only use where tablets or oral solution are not appropriate, or not available"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Dexamethasone: 6 mg once a day intravenously for 7 to 10 days (1.8 ml of 3.3 mg/ml ampoules [5.94 mg])."
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Hydrocortisone: 50 mg every 8 hours intravenously 1,2,3,5."
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Lower doses of hydrocortisone can be continued for up to 28 days for patients with septic shock."
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Treatment should stop if the patient is discharged from hospital before the 10 day course is completed."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Pregnancy and breastfeeding"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 40.0,
                "text": "In  pregnancy  or  breastfeeding  women;  prednisolone   mg  PO  once  daily  (or  IV hydrocortisone 80mg twice a day) should be used instead of dexamethasone1,3,4."
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Paediatric dosing"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "type": "table",
            "sequence_num": 30,
            "data": {
                "num_rows": 3,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Drug"
                    },
                    {
                        "text": "Route"
                    },
                    {
                        "text": "Formulation"
                    },
                    {
                        "text": "Age / Weight"
                    },
                    {
                        "text": "Dose"
                    },
                    {
                        "text": "Duration"
                    },
                    {
                        "text": "Comments"
                    },
                    {
                        "text": "Hydrocortisone"
                    },
                    {
                        "text": "PO/ NG/ IV"
                    },
                    {
                        "text": "Oral tablets/ solution for injection"
                    },
                    {
                        "text": "Neonates including preterm infants with a CGA of \u226444 weeks"
                    },
                    {
                        "text": "0.5 mg/kg every 12 hours for 7 days then 0.5 mg/kg once daily for 3 days"
                    },
                    {
                        "text": "Gastric protection should be co-prescribed"
                    },
                    {
                        "text": "Dexamethasone"
                    },
                    {
                        "text": "PO/ NG/ IV"
                    },
                    {
                        "text": "Oral solution/ tablet/ solution for injection"
                    },
                    {
                        "text": "All >44 weeks CGA"
                    },
                    {
                        "text": "150 micrograms/ kg (base) once daily (max: 6 mg/dose)"
                    },
                    {
                        "text": "10 days"
                    },
                    {
                        "text": "Caution in dosing \u2013 doses are expressed in terms of dexamethasone base Gastric protection should be co-prescribed"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Notes"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Consider the use of proton pump inhibitors in those on full anticoagulation or at risk of peptic ulcer disease"
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 1,
                "text": "If not known to have diabetes check blood glucose and request HbA1c prior to steroids to establish baseline then continue to randomly monitor daily either pre meal or 2hrs after a lunch or evening meal. If any blood glucose is > 12 mmol/l then the frequency of testing should be increased to four times a day and referral made to the Diabetes Inpatient Service"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If known diabetes monitor blood glucose four times a day, before or 2 hours after a meal and before bed and refer to the Diabetes Inpatient Service"
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Consider discontinuation of oral steroids given for other health conditions and restart if necessary when dexamethasone/hydrocortisone discontinued"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 1,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Guideline on use of Corticosteroids for the treatment of COVID-19/MSEGL-20003/1.0"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 38
        }
    ]
}